Our cancer research examines many of the most prevalent cancers today with the goal of finding new and innovative therapies, treatments and ultimately prevention and cures.
Our researchers discovered a link between finasteride, a medication used to relieve urinary problems, and prevention of prostate cancer.
The Mays Cancer Center is a member of The Pediatric Oncology Experimental Therapeutics Investigators' Consortium (POETIC).
Clinical trial participation is an invaluable way to contribute to the pursuit of new treatments for cancer. Take action today! Volunteer and play a role in finding a cure.
Home to the only National Cancer Institute-designated cancer center in South Texas, UT Health San Antonio MD Anderson Cancer Center conducts more than 200 clinical trials in over 30 types of cancers.
The University of Texas Health Science Center at San Antonio broke ground and unveiled the cornerstone for the UT Health San Antonio Multispecialty and Research Hospital, a destination center for research and treatment of cancer and other complex diseases that disproportionately impact the people of South Texas.Read the full story in the Newsroom
The Mary Kay Foundation on Oct. 22 announced that UT Health San Antonio is among its 2020 cancer grant recipients. The grants are awarded annually to top accredited research institutions in the United States conducting innovative translational research to better understand cancers that affect women.Read the article at UT Health San Antonio's Newsroom
In patients with high-grade cancer in the lining of the bladder, cancer often comes back within a year following standard treatment.
Although there are several approved treatments, none have significantly improved survival with few side effects. However, a new study evaluating a novel immunotherapy called nadofaragene firadenovec (NF) gene therapy may offer new hope.Learn more at UT Health San Antonio's Newsroom
UT Health San Antonio and its Mays Cancer Center will receive a $6 million award from the Cancer Prevention and Research Institute of Texas (CPRIT) to recruit Alexander Mazin, PhD, a senior, highly accomplished biochemist and cancer biologist currently at Drexel University College of Medicine.Read the article at UT Health San Antonio's Newsroom